Company: SHPH
Filing Date: 2025-01-21
Form Type: 8-K
Source: 0001493152-25-002945
Chunk: 1

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-01-21
Form: 8-K
Item: Item 8.01
Chunk 1
---

“estimates,” “forecasts,” “intends,” “anticipates,” “does not anticipate”
or “believes,” or variations of such words and phrases, or state that certain actions, events or results “may,”
“could,” “would,” “might,” “projects,” “will,” “will be taken,”
“occur” or “be achieved”). Forward-looking statements are based on the opinions and estimates of management of
the Company, as of the date such statements are made, and they are subject to known and unknown risks, uncertainties, assumptions and
other factors that may cause the actual results, performance or achievements to be materially different from those expressed or implied
by such forward-looking statements. Additional information on these and other factors that may cause actual results and the Company’s
performance to differ materially is included in the Company’s periodic reports filed with the Securities and Exchange Commission,
or the SEC. Copies of the Company’s filings with the SEC are available publicly on the SEC’s website at www. sec. gov. Readers
are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made. These forward-looking
statements are made only as of the date hereof, and the Company undertakes no obligations to update or revise the forward-looking statements,
whether as a result of new information, future events or otherwise, except as required by law.

Item
9.01. Financial Statements and Exhibits.

(d) Exhibits

  Exhibit      Description                                                             
      No.                                                                              
     99.1      Press Release dated January 21, 2025                                    
 ───────────────────────────────────────────────────────────────────────────────────────
      104      Cover                                                                   

SIGNATURES

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

  SHUTTLE                                                 
  By:                                 /s/                 
  Name:                               Anatoly             
  Title:                              Chief